Day 1 – Wednesday 3rd May

09:00 LSX Welcome Address

Nadia Konneh, Senior Conference Director, Healthtech Lead, LSX

09:10 Big Pharma’s Global Digital Health Priorities and Strategy

As pharma moves from a product to a platform focus, the highly strategic approach requires a focus on new infrastructure and services to meet the needs of customers in new ways. The chief heads of digital at top pharma companies will have a high-level discussion about their global digital health strategy, how they plan to improve the use of new tech across their companies, manage data better, foster successful partnerships and collaboration, and generally encouraging the digital health ecosystem worldwide.

• What are your digital priorities (across the entire value chain)?
• How do you plan to manage data better?
• A look into the benefits of mining internal datasets vertically and what new insights can this yield?
• Insights into the challenges and opportunities of external collaboration and partnering with digital disruptors
• How do you develop and deploy patient/ physician facing solutions as quickly as possible?

09:50 Keynote Panel: Scaling Digital Health Companies and Creating Commercially Viable Business Models

With countries and regions across the globe developing and enforcing a plethora of overlapping (and in some cases confusing) regulations on data privacy, protection, and localization, and with EU regulations such as the Digital Markets Act, it is making it difficult for digital health companies to scale up. With profitability also a priority, it is imperative for digital health companies to develop commercially viable business models. This discussion will highlight case studies and best practices for global expansion in the EU & US.

• How the EU’s fragmented digital markets make it hard for companies to scale and what can be done?
• Is the EU prioritising regulation over innovation?
• How do we make Europe a destination of choice for scale up?
• How to drive global expansion into the US market
• Best practices for successful digital health business models in Europe and the US

10:30 Morning Break

11:10 Panel: The Ongoing Digital Transformation of the Healthcare Industry - Entering a New Era of Digital Health at Scale

• The realities of digitally transforming a pharma/ healthcare company and the way they work
• Sharing the wins – what has worked well in your digital transformation journey?
• How can we go further in making our processes more user-centric and efficient?
• The importance of digital innovation to better serve patients, physicians and improve outcomes
• Digitalising and improving treatment algorithms– how can you even digitalise this?

12:00 Panel: Creating Successful Digital Health-Pharma Partnerships and Collaborations

• Partnering with Pharma – what are commercial leaders looking for?
• The need for new collaboration models
• Overcoming roadblocks in digital health and DTx partnerships and collaborations
• How to create win-win partnerships between big pharma and digital innovators
• How to implement AI, machine learning and other emerging technologies into worldwide innovation
• What is the M&A market looking like?

12:50 Lunch Break

14:00 Panel: Getting a Digital Therapeutic Approved and Reimbursed in Europe

• Case studies from DTx companies that have therapeutics approved in Europe
• How to succeed in a fragmented European regulatory landscape
• An overview of the main DTx reimbursement frameworks and practical examples on getting DTx reimbursed
• The challenges of demonstrating evidence across different regulatory and reimbursement requirements
• Commercialisation models: what is working, what is not

14:50 Panel: Evaluating the Digital Therapeutics Investment Landscape Over the Past Year

• How do we get to scale?
• M&A and consolidation: What are the trends?
• Discussing the willingness of investors to fund non-organic growth strategies
• What has been the effect of digital therapeutics companies going public?
• Has adoption been consistent with expectations? (Usage, prescription, revenues generated)

15:40 Afternoon Break

16:20 Panel: Assessing the Progress in the Women’s Health Space

• Can we match the level of deal flow seen in general health?
• What funding opportunities are out there? Where are the funding gaps?
• Insights on how to raise capital - What are investors looking for from women’s health companies?
• Building a product that is consumer friendly and medical grade
• Closing the education gap and improving health literacy

17:00 Closing Keynote Panel- The Healthtech Funding Slump: Are We on The Way Back Up?

• Lessons learned from 2021 and 2022 VC investments in healthtech
• An overview of the European digital health investment activity over the past year
• Digital health M&A activity in Europe and US
• Assessing the current valuation environment
• Notable transactions and growing digital health companies in Europe and US
• What’s next for healthtech funding, finance and investment?

17:40 Drinks Reception

Day 2 – Thursday 4th May

09:00 LSX Welcome Address

Nadia Konneh, Senior Conference Director, Healthtech Lead, LSX

09:10 Keynote Panel: Is Population Health Management Going to Save Healthcare?

Population health management (PHM) is a whole system approach which aims to improve the health of an entire population, while reducing health inequalities. Digital technologies can be used in PHM to enable earlier treatment and diagnosis, large-scale clinical trials, and collect evidence to assess how effective new treatment pathways are.

• How can health systems, payers and digital health companies can work together to support population health management?
• Exploring the relationship between service redesign and analytics
• Population health management strategies to reduce health disparities
• Genomics as a population health management tool in the transition to value-based care
• A spotlight on innovative digital health companies that are building solutions for population health management

09:50 Driving Greater Adoption of HealthTech Innovation Within the NHS and Ensuring a Patient Centric Experience

HealthTech innovation is integral to resolving the long-term challenges faced by the NHS, but many providers in the sector are having difficulty adopting and realising their full potential. What can we do to drive greater adoption and enhance the experience for patients and clinicians?

• Outlining the challenges of HealthTech adoption and how we can overcome this
• How can HealthTech innovation solve the long-term challenges faced by healthcare systems like the NHS?
• Aligning patient/physician perspectives and empowering providers with the full potential of HealthTech solutions

10:30 Morning Break

11:10 Panel: Leveraging Real-World Evidence and Real-World Data

• How is RWE being used and regulated?
• Assessing the adoption of RWD/RWE in R&D and commercially
• How is RWD being used post product approval? How are products being improved upon?
• How have technological advancements helped in scaling the use of RWD/RWE?

12:00 Panel: Making Value-Based Healthcare a Reality

• What exactly do we mean by “value-based healthcare”?
• Is value-based healthcare a sustainable business model?
• How do you demonstrate value to regulators?
• Paying for value and not volume – connecting value to outcomes
• How can digital health drive value-based healthcare?

12:50 Lunch Break

14:00 The race to the Exit: Are Europe’s Digital Health Start-Ups Keener Than Ever to Be Acquired?

• Profitability is priority-the shift in what investors are looking
• The decrease in valuations and cheque sizes
• The need for more capital and the long timeframes to scale profitability for digital health start-ups
• A digital health M&A wave – insight from start-ups who have gone through the acquisition process with larger companies

14:40 Panel: Digital Mental Health 2.0 – Scaling Behavioural Healthtech

• Funding has poured into behavioural health technology start-ups and innovations these last few years, but is it sustainable?
• What are the key challenges in scaling mental health start-ups?
• Building a scalable mental health business model
• Taking an evidence-based approach to mental healthcare tech innovation

15:20 Closing Keynote Panel: How do we build trust in Digital Technology, AI and Data Use?

• Ethical data usage in an era of digital technology and regulation
• The patient as the ultimate data owner
• Engaging the patient in genuine dialogue to build trust in a new digital world

16:00 Close of Congress